Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

BACKGROUND: The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial. We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with standard of care alone in patients admitted to hospital with COVID-19, with indication of oxygen or ventilator supp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ader, Florence, Bouscambert-Duchamp, Maude, Hites, Maya, Peiffer-Smadja, Nathan, Poissy, Julien, Belhadi, Drifa, Diallo, Alpha, Lê, Minh-Patrick, Peytavin, Gilles, Staub, Thérèse, Greil, Richard, Guedj, Jérémie, Paiva, Jose-Artur, Costagliola, Dominique, Yazdanpanah, Yazdan, Burdet, Charles, Mentré, France
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439621/
https://www.ncbi.nlm.nih.gov/pubmed/34534511
http://dx.doi.org/10.1016/S1473-3099(21)00485-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439621/
https://www.ncbi.nlm.nih.gov/pubmed/34534511
http://dx.doi.org/10.1016/S1473-3099(21)00485-0

Ejemplares similares